Si Li

Si Li is the Director of R&D at TCRCure Biopharma Corp. with a background in retroviral vector engineering and engineered T cell therapy. Prior to this role, Si worked as a Graduate Research Assistant at USC Viterbi School of Engineering, focusing on CAR-T cell engineering and CRISPR-Cas9 library design. Si also has experience as a Graduate Teaching Assistant at USC School of Pharmacy. Si holds a Ph.D. in Pharmaceutical Sciences with a specialization in Cancer Immunotherapy from the University of Southern California.